Lifeloc Technologies, Inc (LCTC) Stock Forecast Oct. 14, 2026
Analysis updated on Oct. 14, 2026 (UTC) · Alpha · vs marketSwitch to Total · OTC
Lifeloc Technologies, Inc (LCTC) stock forecast summary
Our AI ranks Lifeloc Technologies, Inc outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
Lifeloc Technologies, Inc is a small-cap company with a market capitalization of $11M. It ranks number 23 by market capitalization among the 25 Laboratory Analytical Instruments issuers in our coverage with a current forecast.
A per-ticker accuracy statistic for LCTC is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.2%, buy ≥ +0.5%, sell < -0.6%, strong sell < -1.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-14 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, LCTC included.
Follow LCTC freeLCTC price chart and AI forecast
How LCTC ranks among 4004 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Lifeloc Technologies, Inc (LCTC) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Laboratory Analytical Instruments peers listed below that report each metric.
Valuation & Market
| Metric | LCTC | Rank |
|---|---|---|
| Market Cap | $11M | 23/25 |
| P/B Ratio | 2.88x | 9/23 |
| EPS | $-0.81 | – |
| Book Value/Share | $1.39 | – |
| Revenue/Share | $3.37 | – |
| FCF/Share | $-0.30 | – |
Profitability & Margins
| Metric | LCTC | Rank |
|---|---|---|
| ROE | -54.3% | 17/21 |
| ROA | -29.3% | 16/22 |
| ROIC | -13.4% | 12/21 |
| Gross Margin | 42.0% | 15/19 |
| Operating Margin | -8.7% | 10/21 |
| Net Margin | -22.3% | 10/20 |
| EBT Margin | -8.4% | 10/22 |
| Tax Rate | -149.5% | – |
The effective tax rate is outside the normal band, which points to a large non-recurring tax item in the trailing twelve months; headline net income, net margin and P/E are affected by it.
Financial Health
| Metric | LCTC | Rank |
|---|---|---|
| Current Ratio | 4.35x | 11/25 |
| Quick Ratio | 1.76x | 14/24 |
| D/E Ratio | 0.85x | 8/24 |
| Financial Leverage | 1.85x | 8/24 |
| Interest Coverage | -3.7x | 9/21 |
| Working Capital | $4M | 23/25 |
Cash Flow
| Metric | LCTC | Rank |
|---|---|---|
| Operating Cash Flow | -$370K | 14/24 |
| Free Cash Flow | -$820K | 11/20 |
| Capital Spending | -$450K | 4/20 |
| FCF/Sales | -8.8% | 13/19 |
| CapEx/Sales | 4.8% | 4/19 |
Operational Efficiency
| Metric | LCTC | Rank |
|---|---|---|
| Asset Turnover | 1.31x | 1/21 |
| Receivables Turnover | 11.2x | 3/19 |
| Inventory Turnover | 1.9x | 10/19 |
| Fixed Assets Turnover | 4.2x | 15/21 |
| Days Sales Outstanding | 33 days | 17/19 |
| Days Inventory | 193 days | 10/19 |
| Payables Period | 34 days | 16/18 |
| Cash Conversion Cycle | 191 days | 9/17 |
Income Statement
| Metric | LCTC | Rank |
|---|---|---|
| Total Revenue | $9M | 19/21 |
| Operating Income | $0.00M | 6/21 |
| Net Income | -$2M | 9/22 |
| R&D Expense | $2M | 21/21 |
| Cost of Goods Sold | $5M | 17/19 |
Dividend & Shareholder Information
| Metric | LCTC | Rank |
|---|---|---|
| Shares Outstanding | 3M | – |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $5M | 67.5% of assets |
| Cash & Short-term Investments | $910K | 12.8% of assets |
| Accounts Receivable | $830K | 11.7% of assets |
| Inventory | $3M | 40.1% of assets |
| Total Liabilities | $3M | 46.0% of assets |
| Short-term Debt | $600K | 8.5% of assets |
LCTC quarterly financials and insider trading
Lifeloc Technologies, Inc (LCTC) industry peers
Companies classified under the same SEC industry code as Lifeloc Technologies, Inc (Laboratory Analytical Instruments): 25 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| LCTC Lifeloc Technologies, Inc | ▲ | $11M |
| A Agilent Technologies, Inc. | ▼ | $48.40B |
| WAT Waters Corp /De/ | ▲ | $42.17B |
| ILMN Illumina, Inc. | ▶ | $40.95B |
| MTD Mettler Toledo International Inc/ | ▼ | $32.02B |
| RVTY Revvity, Inc. | ▼ | $17.30B |
| AVTR Avantor, Inc. | ▶ | $10.62B |
| BIO Bio-Rad Laboratories, Inc. | ▼ | $9.73B |
| TXG 10x Genomics, Inc. | ▲ | $9.35B |
| BRKR Bruker Corp | ▲ | $8.56B |
| ALMR Alamar Biosciences, Inc. | ▶ | $1.63B |
| CTKB Cytek Biosciences, Inc. | ▲ | $695M |
| PACB Pacific Biosciences Of California, Inc. | ▲ | $637M |
| MASS 908 Devices Inc. | ▲ | $500M |
| EYPT Eyepoint, Inc. | ▲ | $265M |
| NAUT Nautilus Biotechnology, Inc. | ▲ | $261M |
| BFNH Bioforce Nanosciences Holdings, Inc. | ▼ | $250M |
| QTRX Quanterix Corp | ▲ | $149M |
| SEER Seer, Inc. | ▶ | $117M |
| RPID Rapid Micro Biosystems, Inc. | ▲ | $44M |
| PRPO Precipio, Inc. | ▲ | $40M |
| HBIO Harvard Bioscience Inc | ▼ | $38M |
| BNGO Bionano Genomics, Inc. | ▲ | $16M |
| ASTC Astrotech Corp | ▶ | $11M |
| SCND Scientific Industries Inc | ▲ | $8M |
Where LCTC sits on the market map
Lifeloc Technologies, Inc (LCTC) stock news
Loading...
Lifeloc Technologies, Inc (LCTC) stock forecast FAQ
What is the Lifeloc Technologies, Inc (LCTC) stock forecast?
Our AI ranks Lifeloc Technologies, Inc outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
How accurate are Lifeloc Technologies, Inc stock predictions?
A per-ticker accuracy statistic for LCTC is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Lifeloc Technologies, Inc forecasts updated?
Lifeloc Technologies, Inc forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 14, 2026.
Which companies are Lifeloc Technologies, Inc's industry peers?
25 issuers in our coverage, LCTC included, share the SEC industry code Laboratory Analytical Instruments. The largest are: Agilent Technologies, Inc. (A), Waters Corp /De/ (WAT), Illumina, Inc. (ILMN), Mettler Toledo International Inc/ (MTD), Revvity, Inc. (RVTY), Avantor, Inc. (AVTR).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.